Impacts of Prism Adaptation Treatment on Spatial Neglect and Rehabilitation Outcome - Dosage Matters-Ep46
KesslerFoundation.org

PEII CHEN: 00:08
[music] And this article is to share the obstacles that we encountered over the past
five, six years when we're implementing both KF-NAP, KF-PAT.

JOAN BANKS-SMITH: 00:20
That was Dr. Peii Chen, senior research scientist at our Center for Stroke
Rehabilitation Research. This is Kessler Foundation's Fast Takes. Research that
changes lives. I'm your host, Joan Banks-Smith. In this episode, Dr. Chen talks about
her journal article Impacts of Prism Adaptation Treatment on Spatial Neglect and
Rehabilitation Outcome: Dosage Matters. This was e-published on June 8th, 2022, in
the journal, Neurorehabilitation and Neural Repair. The funding source was the
Wallerstein Foundation for Geriatric Improvement and the Charles and Anne Siriano
Foundation. Dr. Chen, what are the main takeaways of this study?
CHEN 01:06 What we found is receiving more once-daily prism adaptation treatment sessions
predicted greater improvement in spatial neglect and rehabilitation outcomes in
inpatient rehabilitation facility settings. This is very important, especially in the United
States, because patients, stroke patients, or brain injury patients, their length of stay
inpatient rehabilitation facilities are relatively short. It's about two to three weeks.
And previously, many clinicians have shared with me and my team that they do not
have enough time to provide the recommended 10 sessions during inpatient stay.
Now, this analysis shows that even if they cannot put in 10 sessions during inpatient
stay, if they can put 3, 4, 5 sessions, as long as more sessions they can put in, there is
a better chance that patients will improve in spatial neglect and rehab outcome in
general.

BANKS-SMITH: 02:11
Dr. Chen, what are the main takeaways of this study?

CHEN: 02:14
I would say it's very promising for researchers to create new prospective studies to
look at what we found through this retrospective regression correlation analysis and
to verify each findings that's specified in the research paper itself and provide
conversion evidence that prism adaptation is effective. For clinical practice, it really is
to verify the effectiveness of prism adaptation to some clinicians who do not think it
may be effective previously. And now, there's more evidence directly from clinical
data that tells them, "Hey, prism adaptation now have beneficial impact on patient's
outcome," and they should try or communicate with clinicians or our research team
how and why it works.

BANKS-SMITH: 03:19
To learn more about Dr. Chen, her peer-reviewed article, the Center for Stroke
Rehabilitation Research, and me, your podcast host, links are in the program notes.
Tuned into our podcast series lately? Join our listeners in 90 countries who enjoy
learning about the work of Kessler Foundation. Be sure and subscribe to our
SoundCloud channel, Kessler Foundation, for more research updates. Follow us on
Facebook, Twitter, and Instagram. Listen to us on Apple Podcast, Spotify, SoundCloud,
or wherever you get your podcasts. This podcast was recorded on August 9th
remotely, and was edited and produced by me, Joan Banks-Smith, creative producer for Kessler Foundation. [music]